Pulmicort CFC-free range

In line with the global phase-out of chlorofluorocarbon (CFC)-containing inhalers in favour of inhalers that use more environmentally friendly CFC-free propellants, AstraZeneca has launched Pulmicort (budesonide) 200 microgram CFC-free metered dose inhaler (MDI).

This is the latest addition to the company's range of CFC-free MDIs, which includes the Pulmicort 100 microgram CFC-free MDI.

View Pulmicort CFC-free drug record

Further information: AstraZeneca

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases